Related Experiment Video
Updated: May 20, 2025
A Reversible Silicon Oil-Induced Ocular Hypertension Model in Mice
Published on: November 15, 2019
Silicone Oil and Glaucoma-Related Adverse Events in Pediatric Vitreoretinal Surgery
Meghan Sharma1, Laura Huertas2, David J Taylor Gonzalez3
1John A. Moran Eye Center at the University of Utah Health, Salt Lake City, Utah.
Insights
Pediatric patients undergoing vitreoretinal surgery with silicone oil experienced a higher risk of glaucoma-related adverse events (GRAEs). Close monitoring for glaucoma is crucial after these procedures in children.
Area of Science:
- Ophthalmology
- Pediatric Surgery
Background:
- Silicone oil is used in vitreoretinal surgery.
- Glaucoma-related adverse events (GRAEs) are a concern in pediatric patients post-surgery.
Purpose of the Study:
- To assess the risk of GRAEs in pediatric patients after silicone oil use in vitreoretinal (VR) surgery.
- To determine if silicone oil exposure increases GRAE risk.
Main Methods:
- Retrospective cohort study of 186 pediatric patients (0-18 years) undergoing VR surgery.
- Medical records were reviewed for silicone oil use and postoperative GRAEs.
- Survival analysis compared GRAE incidence between silicone oil-exposed and non-exposed groups.
Main Results:
- 102 patients (54.8%) developed GRAEs.
- Silicone oil exposure was associated with a 52% increased risk of GRAE (HR: 1.52, P=0.0425).
- Median time to GRAE was significantly shorter for patients exposed to silicone oil (2.0 months vs. 25.3 months).
Conclusions:
- GRAEs are common after pediatric VR surgery, especially with silicone oil use.
- Silicone oil exposure is a risk factor for GRAEs in this population.
- Emphasizes the need for vigilant glaucoma surveillance in children post-VR surgery.
Purpose:
This study aims to assess the risk of glaucoma-related adverse events (GRAEs) in pediatric patients following silicone oil use in vitreoretinal (VR) surgery, positing that silicone oil exposure increases GRAE risk.
Design:
A single-center retrospective cohort study at a tertiary care facility.
Participants:
Pediatric patients aged 0 to 18 years who underwent VR surgery between April 2019 and April 2021 were included. Patients with previously diagnosed glaucoma or who had undergone glaucoma surgery were excluded.
Methods:
Review of medical records for intraoperative use of silicone oil and postoperative occurrence of GRAE, defined as elevated intraocular pressure (>21 mmHg), initiation of pressure-lowering medications, performance of pressure-lowering surgery, or a diagnosis of childhood glaucoma based on the Childhood Glaucoma Research Network criteria.
Main Outcome Measures:
Survival analysis of GRAE between patients exposed vs. not exposed to silicone oil during VR surgery.
Results:
Of the 186 pediatric patients analyzed, 64 (34.4%) were exposed to silicone oil, and 102 developed GRAE (54.8%). Median survival time to GRAE was 2.0 months (95% confidence interval [CI]: 0.3, 7.7) for silicone oil exposure in patients vs. 25.3 months (95% CI: 3.6, N/A) for patients not exposed to silicone oil (P = 0.0045). Patients exposed to silicone oil had a 52% increased risk of GRAE compared to those not exposed to silicone oil when adjusted for age at VR surgery (hazard ratio: 1.52 [95% CI: 1.01, 2.28], P = 0.0425).
Conclusions:
In this exploratory study, GRAE was commonly observed following pediatric VR surgery, particularly in patients exposed to silicone oil. These findings underscore the importance of careful glaucoma surveillance following VR surgery in children.
Financial Disclosure(S):
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
01:25Glaucoma: Overview